Amylyx Pharmaceuticals (AMLX) Research & Development (2021 - 2026)
Amylyx Pharmaceuticals' Research & Development came in at $23.77 million for Q2 2026, down 12.7% from $27.22 million a year earlier and down 13.9% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Research & Development (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Amylyx Pharmaceuticals reported Research & Development of $92.45 million, down 1.1% year-over-year; for FY2025, it was $90.4 million, down 13.1% from FY2024.
- Research & Development carries a four-year compound annual growth rate of 19.7% (FY2021 to FY2025).
- Going back by year, Research & Development was $104.08 million in FY2024 (-18.8%), $128.19 million in FY2023 (+37.2%), $93.45 million in FY2022 (+112.2%) and $44.04 million in FY2021.
- The five-year range for quarterly Research & Development is $12.85 million (Q3 2021) to $44.91 million (Q4 2023).
- Year-over-year, Research & Development increased in two of the last eight quarters, with an average decline of 12.9%.
- The fastest year-over-year change in Research & Development over five years came in Q1 2022 (growth of 212.7%), and the weakest in Q4 2024 (a decline of 49.0%).
- Business Quant data shows AMLX's Research & Development at $27.61 million (Q1 2026), $21.21 million (Q4 2025) and $19.86 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Amylyx Pharmaceuticals | 3.32 Bn | 3.32 Bn | - | 23.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.77 Mn |
| Mar 31, 2026 | 27.61 Mn |
| Dec 31, 2025 | 21.21 Mn |
| Sep 30, 2025 | 19.86 Mn |
| Jun 30, 2025 | 27.22 Mn |
| Mar 31, 2025 | 22.12 Mn |
| Dec 31, 2024 | 22.89 Mn |
| Sep 30, 2024 | 21.24 Mn |
| Jun 30, 2024 | 23.35 Mn |
| Mar 31, 2024 | 36.61 Mn |
| Dec 31, 2023 | 44.91 Mn |
| Sep 30, 2023 | 30.04 Mn |
| Jun 30, 2023 | 29.04 Mn |
| Mar 31, 2023 | 24.19 Mn |
| Dec 31, 2022 | 22.81 Mn |
| Sep 30, 2022 | 24.91 Mn |
| Jun 30, 2022 | 24.26 Mn |
| Mar 31, 2022 | 21.46 Mn |
| Dec 31, 2021 | 13.39 Mn |
| Sep 30, 2021 | 12.85 Mn |
API Access
Amylyx Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();